Response to growth hormone in patients with RNPC3 mutations

Response to growth hormone in patients with RNPC3 mutations

Graphical Abstract After 6 years of Growth Hormone (GH) therapy, three patients with a defect in minor spliceosome mRNA processing leading to an incompletely understood GH deficit present with excellent auxological response and improvement in the bone mineral density and trabecular bone structure.

Saved in:
Bibliographic Details
Main Authors: Gabriel Á Martos‐Moreno, Lourdes Travieso‐Suárez, Jesús Pozo‐Román, María T Muñoz‐Calvo, Julie A Chowen, Mikko J Frilander, Luis A Pérez‐Jurado, Federico G Hawkins, Jesús Argente
Format: Article
Language:English
Published: Springer Nature 2018-06-01
Series:EMBO Molecular Medicine
Online Access:https://doi.org/10.15252/emmm.201809143
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Graphical Abstract After 6 years of Growth Hormone (GH) therapy, three patients with a defect in minor spliceosome mRNA processing leading to an incompletely understood GH deficit present with excellent auxological response and improvement in the bone mineral density and trabecular bone structure.
ISSN:1757-4676
1757-4684

Similar Items